SGRY
Surgery Partners Inc

863
Loading...
Loading...
News
all
press releases
Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates
Surgery Partners (SGRY) delivered earnings and revenue surprises of +6.25% and +0.15%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
More News
News Placeholder
Danaher (DHR) Q2 Earnings and Revenues Top Estimates
Danaher (DHR) delivered earnings and revenue surprises of +9.76% and +1.71%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Surgery Partners Stock Slumps 13% After Company Rejects Bain Capital’s Take-Private Proposal
Chairman of the Independent Committee, Brent Turner, said the best path forward for Surgery Partners is to continue operating as an independent publicly traded company.
Stocktwits·3mo ago
News Placeholder
9 Analysts Assess Surgery Partners: What You Need To Know
Latest Ratings for SGRY DateFirmActionFromTo Mar 2022JP MorganMaintainsNeutral Mar 2022SVB LeerinkMaintainsOutperform Mar 2022RBC CapitalMaintainsOutperform View More Analyst Ratings for SGRY...
Benzinga·11mo ago
News Placeholder
What 8 Analyst Ratings Have To Say About Surgery Partners
Latest Ratings for SGRY DateFirmActionFromTo Mar 2022JP MorganMaintainsNeutral Mar 2022SVB LeerinkMaintainsOutperform Mar 2022RBC CapitalMaintainsOutperform View More Analyst Ratings for SGRY...
Benzinga·1y ago
News Placeholder
Surgery Partners (SGRY) Poised for Upside: A Comprehensive Buy Rating Justification
In a report released on July 18, Whit Mayo from Leerink Partners reiterated a Buy rating on Surgery Partners (SGRY Research Report), with a price...
TipRanks Financial Blog·1y ago
News Placeholder
Critical Insights From Surgery Partners Analyst Ratings: What You Need To Know
Latest Ratings for SGRY DateFirmActionFromTo Mar 2022JP MorganMaintainsNeutral Mar 2022SVB LeerinkMaintainsOutperform Mar 2022RBC CapitalMaintainsOutperform View More Analyst Ratings for SGRY...
Benzinga·1y ago
News Placeholder
While shareholders of Surgery Partners (NASDAQ:SGRY) are in the black over 5 years, those who bought a week ago aren't so fortunate
Surgery Partners, Inc. ( NASDAQ:SGRY ) shareholders might be concerned after seeing the share price drop 13% in the...
Simply Wall St·1y ago
News Placeholder
Surgery Partners: A Buy Rating Amidst Underperformance and Growth Potential
Analyst Whit Mayo of Leerink Partners reiterated a Buy rating on Surgery Partners (SGRY Research Report), retaining the price target of $47.00. W...
TipRanks Financial Blog·1y ago
News Placeholder
Surgery Partners (SGRY, $29.94) Stochastic Oscillator left the overbought zone on March 27, 2024
This is a signal that SGRY's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...
Tickeron - Stocks·1y ago

Latest SGRY News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.